TY - JOUR
T1 - Activity and high-order effective connectivity alterations in sanfilippo C patient-specific neuronal networks
AU - Canals, Isaac
AU - Soriano, Jordi
AU - Orlandi, Javier G.
AU - Torrent, Roger
AU - Richaud-Patin, Yvonne
AU - Jiménez-Delgado, Senda
AU - Merlin, Simone
AU - Follenzi, Antonia
AU - Consiglio, Antonella
AU - Vilageliu, Lluïsa
AU - Grinberg, Daniel
AU - Raya, Angel
N1 - Publisher Copyright:
© 2015 The Authors.
PY - 2015/10/13
Y1 - 2015/10/13
N2 - Induced pluripotent stem cell (iPSC) technology has been successfully used to recapitulate phenotypic traits of several human diseases in vitro. Patient-specific iPSC-based disease models are also expected to reveal early functional phenotypes, although this remains to be proved. Here, we generated iPSC lines from two patients with Sanfilippo type C syndrome, a lysosomal storage disorder with inheritable progressive neurodegeneration. Mature neurons obtained from patient-specific iPSC lines recapitulated the main known phenotypes of the disease, not present in genetically corrected patient-specific iPSC-derived cultures. Moreover, neuronal networks organized in vitro from mature patient-derived neurons showed early defects in neuronal activity, network-wide degradation, and altered effective connectivity. Our findings establish the importance of iPSC-based technology to identify early functional phenotypes, which can in turn shed light on the pathological mechanisms occurring in Sanfilippo syndrome. This technology also has the potential to provide valuable readouts to screen compounds, which can prevent the onset of neurodegeneration.
AB - Induced pluripotent stem cell (iPSC) technology has been successfully used to recapitulate phenotypic traits of several human diseases in vitro. Patient-specific iPSC-based disease models are also expected to reveal early functional phenotypes, although this remains to be proved. Here, we generated iPSC lines from two patients with Sanfilippo type C syndrome, a lysosomal storage disorder with inheritable progressive neurodegeneration. Mature neurons obtained from patient-specific iPSC lines recapitulated the main known phenotypes of the disease, not present in genetically corrected patient-specific iPSC-derived cultures. Moreover, neuronal networks organized in vitro from mature patient-derived neurons showed early defects in neuronal activity, network-wide degradation, and altered effective connectivity. Our findings establish the importance of iPSC-based technology to identify early functional phenotypes, which can in turn shed light on the pathological mechanisms occurring in Sanfilippo syndrome. This technology also has the potential to provide valuable readouts to screen compounds, which can prevent the onset of neurodegeneration.
UR - http://www.scopus.com/inward/record.url?scp=84944412953&partnerID=8YFLogxK
U2 - 10.1016/j.stemcr.2015.08.016
DO - 10.1016/j.stemcr.2015.08.016
M3 - Article
SN - 2213-6711
VL - 5
SP - 546
EP - 557
JO - Stem Cell Reports
JF - Stem Cell Reports
IS - 4
ER -